Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A.H. de Vries-Schultink
Pcn191 - Cost-Effectiveness of Monitoring Endoxifen Levels in Breast Cancer Patients Adjuvantly Treated With Tamoxifen
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated With Tamoxifen
Frontiers in Pharmacology
Pharmacology
Limited Predictive Value of Achieving Beneficial Plasma (Z)-Endoxifen Threshold Level by CYP2D6 Genotyping in Tamoxifen-Treated Polish Women With Breast Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Cost-Effectiveness of Anastrozole, in Comparison With Tamoxifen, in the Adjuvant Treatment of Early Breast Cancer in Brazil
Revista da Associacao Medica Brasileira
Medicine
Comprehensive CYP2D6 Genotype and Adherence Affect Outcome in Breast Cancer Patients Treated With Tamoxifen Monotherapy
Breast Cancer Research and Treatment
Cancer Research
Oncology
Cost-Effectiveness of Lymphadenectomy in Patients With Early Breast Cancer Luminal Type A
Tumors of female reproductive system
Persistence in Patients With Breast Cancer Treated With Tamoxifen or Aromatase Inhibitors- Analysis Based on Oncology Analyzer Database
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Transcriptomic Signature Predicts the Distant Relapse in Patients With ER+ Breast Cancer Treated With Tamoxifen for Five Years
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Tamoxifen and Mastectomy for Elderly Patients With Operable Breast Cancer.
BMJ
The Active Tamoxifen Metabolite Endoxifen (4OHNDtam) Strongly Down-Regulates Cytokeratin 6 (CK6) in McF-7 Breast Cancer Cells
PLoS ONE
Multidisciplinary
